Design of Glucagon-Like Peptide-1 Receptor Agonist for Diabetes Mellitus from Traditional Chinese Medicine

Figure 3

Docking poses by the LIGPLOT program. (a) Wenyujinoside, (b) 28-deglucosylchikusetsusaponin IV, and the control: (c) GLP1.

(a)

(b)

(c)